Cargando…
Reactions Related to CAR-T Cell Therapy
The application of chimeric antigen receptor (CAR) T-cell therapy as a tumor immunotherapy has received great interest in recent years. This therapeutic approach has been used to treat hematological malignancies solid tumors. However, it is associated with adverse reactions such as, cytokine release...
Autores principales: | Miao, Lele, Zhang, Zhengchao, Ren, Zhijian, Li, Yumin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113953/ https://www.ncbi.nlm.nih.gov/pubmed/33995389 http://dx.doi.org/10.3389/fimmu.2021.663201 |
Ejemplares similares
-
Gene-Edited Interleukin CAR-T Cells Therapy in the Treatment of Malignancies: Present and Future
por: Zhang, Zhengchao, et al.
Publicado: (2021) -
Obstacles and Coping Strategies of CAR-T Cell Immunotherapy in Solid Tumors
por: Miao, Lele, et al.
Publicado: (2021) -
A Bibliometric and Knowledge-Map Analysis of CAR-T Cells From 2009 to 2021
por: Miao, Lele, et al.
Publicado: (2022) -
A promising antitumor method: Targeting CSC with immune cells modified with CAR
por: Huang, Binjie, et al.
Publicado: (2022) -
Application of Immunotherapy in Hepatocellular Carcinoma
por: Miao, Lele, et al.
Publicado: (2021)